2 Einträge gefunden

1. Benefit-risk perception of natalizumab therapy in neurologists and a large cohort of multiple sclerosis patients

   1. Heesen, Christoph
   2. Kleiter, Ingo
   3. Meuth, Sven G
   4. Krämer, Julia
   5. Kasper, Jürgen
   6. Köpke, Sascha
   7. Gaissmaier, Wolfgang

   2017 - Forschungsinformationssystem des UKE
2. Is the risk of progressive multifocal leukoencephalopathy the real reason for natalizumab discontinuation in patients with multiple sclerosis?

   1. Krämer, Julia
   2. Tenberge, Jan-Gerd
   3. Kleiter, Ingo
   4. Gaissmaier, Wolfgang
   5. Ruck, Tobias
   6. Heesen, Christoph
   7. Meuth, Sven G

   2017 - Forschungsinformationssystem des UKE - frei zugänglich